ADRB3 and Alzheimer disease: Previous studies, both these co-authors and others, also reached the same conclusion, where activation of β3-AR, but not β2, reduced Aβ and its production and prevented the associated memory loss in an AD model (Gibbs et al., 2010; Tournissac et al., 2021); these facts support our findings.